Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids.
9-Fluorenylmethoxycarbonyl (Fmoc) amino acids were first used for solid phase peptide synthesis a little more than a decade ago. Since that time, Fmoc solid phase peptide synthesis methodology has been greatly enhanced by the introduction of a variety of solid supports, linkages, and side chain protecting groups, as well as by increased understanding of solvation conditions. These advances have led to many impressive syntheses, such as those of biologically active and isotopically labeled peptides and small proteins. The great variety of conditions under which Fmoc solid phase peptide synthesis may be carried out represents a truly "orthogonal" scheme, and thus offers many unique opportunities for bioorganic chemistry.
Fields
G B
GB
Department of Pharmaceutical Chemistry, University of California, San Francisco.
Noble
R L
RL
D000596:Amino Acids; D055598:Chemical Phenomena; D002621:Chemistry; D002627:Chemistry, Physical; D005449:Fluorenes; D008854:Microscopy, Electron; D015394:Molecular Structure; D010455:Peptides / Q000138:chemical synthesis*; D012116:Resins, Plant; D012997:Solvents
D000596:Amino Acids; D005449:Fluorenes; C016456:N(alpha)-fluorenylmethyloxycarbonylamino acids; D010455:Peptides; D012116:Resins, Plant; D012997:Solvents